Biotech · Private company
Glaukos Corporation
Track this companyFree. Adds Glaukos Corporation to your Dealase workspace and tells you when its record changes.
Clinical trials2512 recruiting or active
Pipeline programs54From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline54
- G2-TR intraocular implant containing travoprostPhase 3 · Glaucoma, Open-AngleClinicalTrials.gov · fetched Nov 12, 2026
- Gen 2 Travoprost Intracameral ImplantPhase 3 · GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
- KXL medical device systemPhase 3 · Progressive KeratoconusClinicalTrials.gov · fetched Nov 12, 2026
- Sham ProcedurePhase 3 · GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
- Sham surgery + active-comparator eye dropsPhase 3 · Glaucoma, Open-AngleClinicalTrials.gov · fetched Nov 12, 2026
- Test Article APhase 3 · Progressive KeratoconusClinicalTrials.gov · fetched Nov 12, 2026
- Test Article BPhase 3 · Progressive KeratoconusClinicalTrials.gov · fetched Nov 12, 2026
- Timolol eye drops 0.5%Phase 3 · GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
- GLK-221 Ophthalmic SolutionPhase 2 · KeratoconusClinicalTrials.gov · fetched Nov 12, 2026
- GLK-321 high dose BIDPhase 2 · Demodex BlepharitisClinicalTrials.gov · fetched Nov 12, 2026
- GLK-321 high dose QDPhase 2 · Demodex BlepharitisClinicalTrials.gov · fetched Nov 12, 2026
- GLK-321 low dose BIDPhase 2 · Demodex BlepharitisClinicalTrials.gov · fetched Nov 12, 2026
- GLK-321 mid dose BIDPhase 2 · Demodex BlepharitisClinicalTrials.gov · fetched Nov 12, 2026
- lufepirsen high dosePhase 2 · Persistent Corneal Epithelial DefectClinicalTrials.gov · fetched Nov 12, 2026
- lufepirsen low dosePhase 2 · Persistent Corneal Epithelial DefectClinicalTrials.gov · fetched Nov 12, 2026
- Nexagon® (lufepirsen) High Dose ConcentrationPhase 2 · Corneal Persistent Epithelial DefectClinicalTrials.gov · fetched Nov 12, 2026
- Nexagon® (lufepirsen) Low Dose ConcentrationPhase 2 · Corneal Persistent Epithelial DefectClinicalTrials.gov · fetched Nov 12, 2026
- NXL Energy 1Phase 2 · Progressive KeratoconusClinicalTrials.gov · fetched Nov 12, 2026
- NXL Energy 2Phase 2 · Progressive KeratoconusClinicalTrials.gov · fetched Nov 12, 2026
- NXL Energy 3Phase 2 · Progressive KeratoconusClinicalTrials.gov · fetched Nov 12, 2026
- Open-label Nexagon® (lufepirsen)Phase 2 · Corneal Persistent Epithelial DefectClinicalTrials.gov · fetched Nov 12, 2026
- Pilocarpine Ophthalmic Topical Cream, Dose 1Phase 2 · Dry Eye DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Pilocarpine Ophthalmic Topical Cream, Dose 1Phase 2 · PresbyopiaClinicalTrials.gov · fetched Nov 12, 2026
- Pilocarpine Ophthalmic Topical Cream, Dose 2Phase 2 · PresbyopiaClinicalTrials.gov · fetched Nov 12, 2026
- Pilocarpine Ophthalmic Topical Cream, Dose 2Phase 2 · Dry Eye DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Pilocarpine Ophthalmic Topical Cream, Dose 3Phase 2 · Dry Eye DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Pilocarpine Ophthalmic Topical Cream, Dose 3Phase 2 · PresbyopiaClinicalTrials.gov · fetched Nov 12, 2026
- Sham TreatmentPhase 2 · Progressive KeratoconusClinicalTrials.gov · fetched Nov 12, 2026
- Timolol maleate ophthalmic solution, 0.5%Phase 2 · Open Angle GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
- Timolol Maleate Ophthalmic Solution, 0.5%Phase 2 · Glaucoma Open-angleClinicalTrials.gov · fetched Nov 12, 2026
- TravoprostPhase 2 · Open Angle GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
- Travoprost Intraocular Implant, high elutionPhase 2 · Glaucoma Open-angleClinicalTrials.gov · fetched Nov 12, 2026
- Travoprost Intraocular Implant, low elutionPhase 2 · Glaucoma Open-angleClinicalTrials.gov · fetched Nov 12, 2026
- Travoprost Ophthalmic Solution, 0.004%Phase 2 · Open Angle GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
- Travoprost Ophthalmic Topical Cream high-dosePhase 2 · Open Angle GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
- Travoprost Ophthalmic Topical Cream low-dosePhase 2 · Open Angle GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
- Travoprost Ophthalmic Topical Cream mid-dosePhase 2 · Open Angle GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 2 · Persistent Corneal Epithelial DefectClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 2 · Corneal Persistent Epithelial DefectClinicalTrials.gov · fetched Nov 12, 2026
- Corneal Collagen Cross-linkingCorneal EctasiaClinicalTrials.gov · fetched Nov 12, 2026
- iDose TR (travoprost intracameral implant) 75 µgOpen Angle Glaucoma (OAG)ClinicalTrials.gov · fetched Nov 12, 2026
- iDose TR (travoprost intracameral implant) 75 µg in conjunction with cataract surgeryGlaucoma, Open-angleClinicalTrials.gov · fetched Nov 12, 2026
- iStent infiniteGlaucoma, Open-AngleClinicalTrials.gov · fetched Nov 12, 2026
- iStent InfiniteGlaucomaClinicalTrials.gov · fetched Nov 12, 2026
- iStent Inject ImplantationGlaucoma, Open-AngleClinicalTrials.gov · fetched Nov 12, 2026
- LaserPrimary Open-Angle GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
- Laser TrabeculoplastyPrimary Open-Angle GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
- Riboflavin Ophthalmic SolutionsKeratoconusClinicalTrials.gov · fetched Nov 12, 2026
- Sham procedureGlaucoma, Open-AngleClinicalTrials.gov · fetched Nov 12, 2026
- Sham procedure in conjunction with cataract surgeryGlaucoma, Open-angleClinicalTrials.gov · fetched Nov 12, 2026
- StentsPrimary Open-Angle GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
- TravoprostOpen Angle Glaucoma (OAG)ClinicalTrials.gov · fetched Nov 12, 2026
- Travoprost Intraocular ImplantGlaucoma, Open-AngleClinicalTrials.gov · fetched Nov 12, 2026
- UV-A Irradiation SystemKeratoconusClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- iDose TR Administration in an Office-Based Surgery SettingRECRUITING · started May 13, 2026ClinicalTrials.gov NCT07816692 · fetched Nov 12, 2026
- Evaluate the Safety and Feasibility of Same-Day Bilateral Epithelium-On Corneal Cross-Linking for KeratoconusPHASE4 · RECRUITING · started May 11, 2026ClinicalTrials.gov NCT07629557 · fetched Nov 12, 2026
- Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral ImplantPHASE3 · RECRUITING · started Feb 17, 2026ClinicalTrials.gov NCT07495852 · fetched Nov 12, 2026
- Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle GlaucomaPHASE4 · RECRUITING · started Jan 5, 2026ClinicalTrials.gov NCT07228221 · fetched Nov 12, 2026
- Placebo-controlled Study to Evaluate the Safety and Efficacy of GLK-221 Ophthalmic Solution in Subjects With KeratoconusPHASE2 · RECRUITING · started Dec 23, 2025ClinicalTrials.gov NCT07400952 · fetched Nov 12, 2026
- Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcgRECRUITING · started Dec 17, 2025ClinicalTrials.gov NCT07400926 · fetched Nov 12, 2026
- Evaluation of the Safety and Efficacy of GLK-321 in Subjects With Demodex BlepharitisPHASE2 · RECRUITING · started Dec 5, 2025ClinicalTrials.gov NCT07400965 · fetched Nov 12, 2026
- Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral ImplantPHASE2 · RECRUITING · started Jun 12, 2025ClinicalTrials.gov NCT07075718 · fetched Nov 12, 2026
- Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery AlonePHASE4 · RECRUITING · started Jan 13, 2025ClinicalTrials.gov NCT06848946 · fetched Nov 12, 2026
- Travoprost Ophthalmic Topical Cream for Open-angle Glaucoma or Ocular HypertensionPHASE2 · UNKNOWN · started Nov 15, 2023ClinicalTrials.gov NCT06152861 · fetched Nov 12, 2026
- Travoprost Intraocular Implant + iStent InfinitePHASE4 · RECRUITING · started Sep 14, 2023ClinicalTrials.gov NCT06066645 · fetched Nov 12, 2026
- Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle GlaucomaNA · RECRUITING · started Sep 1, 2023ClinicalTrials.gov NCT06057051 · fetched Nov 12, 2026
- A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCEDPHASE2 · RECRUITING · started Aug 17, 2023ClinicalTrials.gov NCT05966493 · fetched Nov 12, 2026
- Safety and Efficacy of Corneal Cross-linking in Subjects With KeratoconusPHASE1_PHASE2 · UNKNOWN · started Mar 8, 2022ClinicalTrials.gov NCT05314738 · fetched Nov 12, 2026
- Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of PresbyopiaPHASE2 · COMPLETED · started Jan 3, 2022ClinicalTrials.gov NCT05124275 · fetched Nov 12, 2026
- Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Dry Eye DiseasePHASE2 · COMPLETED · started Jan 3, 2022ClinicalTrials.gov NCT05119920 · fetched Nov 12, 2026
- Study of Exchange of Travoprost Intraocular ImplantPHASE2 · COMPLETED · started Nov 19, 2020ClinicalTrials.gov NCT04615403 · fetched Nov 12, 2026
- iStent Inject New Enrollment Post-Approval StudyNA · UNKNOWN · started Sep 22, 2020ClinicalTrials.gov NCT04624698 · fetched Nov 12, 2026
- NEXAGON for the Treatment of Corneal Persistent Epithelial Defects Following Severe Ocular InjuriesPHASE2 · TERMINATED · started Jun 30, 2020ClinicalTrials.gov NCT04081103 · fetched Nov 12, 2026
- Clinical Study Comparing Two Models of a Travoprost Intraocular ImplantPHASE3 · COMPLETED · started Sep 17, 2018ClinicalTrials.gov NCT03868124 · fetched Nov 12, 2026
- Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%PHASE3 · COMPLETED · started Jul 26, 2018ClinicalTrials.gov NCT03519386 · fetched Nov 12, 2026
- Study to Evaluate the Safety and Efficacy of Epi-on Corneal Cross-linking in Eyes With Progressive KeratoconusPHASE3 · COMPLETED · started Apr 6, 2018ClinicalTrials.gov NCT03442751 · fetched Nov 12, 2026
- Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive SurgeryUNKNOWN · started Oct 4, 2017ClinicalTrials.gov NCT03319082 · fetched Nov 12, 2026
- Study Comparing Travoprost Intraocular Implants to Timolol Ophthalmic SolutionPHASE2 · COMPLETED · started Mar 29, 2016ClinicalTrials.gov NCT02754596 · fetched Nov 12, 2026
- Multicenter Investigation of Trabecular Micro-Bypass Stents vs. Laser TrabeculoplastyNA · TERMINATED · started Dec 16, 2014ClinicalTrials.gov NCT02327312 · fetched Nov 12, 2026